Microsaic Systems plc Agreement (8666B)
April 07 2017 - 2:00AM
UK Regulatory
TIDMMSYS
RNS Number : 8666B
Microsaic Systems plc
07 April 2017
7 April 2017
Microsaic Systems plc
("Microsaic", "Microsaic Systems" or the "Company")
Microsaic signs amended agreement with Global Partner
Microsaic Systems plc (AIM: MSYS), the developer of chip-based
mass spectrometry instruments, announces that it has signed an
amendment to its Research Collaboration Agreement with a long
standing global partner. The amended agreement is a precursor to
future collaboration in the area of bio-processing.
Interim Chairman, Eric Yeatman commented:
"We are delighted to sign this agreement with one of the
foremost players in the global market for scientific
instrumentation, which is in line with the Company's strategy to
focus on application areas in biopharma."
The information contained within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulations (EU) No. 596/2014. Upon the publication of this
announcement, this inside information is now considered to be in
the public domain.
Enquiries:
Microsaic Systems plc
Jim Ramage, CEO
Bevan Metcalf, FD +44 (0) 1483 751577
N+1 Singer (Nominated Adviser
& Broker)
Shaun Dobson
Liz Yong +44 (0)20 7496 3000
Citigate Dewe Rogerson
(Financial PR)
Mark Swallow, Marine Perrier +44 (0)20 7282 2948/1068
About Microsaic Systems
Microsaic Systems plc is a high technology company developing
chip-based, bench-top mass spectrometry ("MS") instruments that are
designed to improve the efficiency of Pharma R&D. MS is an
analytical technique of choice for biochemists across many industry
sectors.
Microsaic aims to bring routine MS analysis to the
pharmaceutical scientist, providing powerful methods of analysis to
enable earlier decision making relating to product identification,
purity and bioactivity.
The Company is working with established global companies in
preparative and purification science with expertise in Pharma and
life sciences to co-develop new, integrated and optimised,
application-specific, solutions to improve productivity in the
development of small molecule and novel biologic (peptides,
antibodies) medicines.
The Microsaic 4000 MiD(R), single quadrupole, is the world's
smallest MS system, retaining the functionality of larger
conventional MS systems, is easier to use by non-specialists,
consumes less energy and has lower running costs. The Company is
also developing new MS systems, based on its patented chip
technologies, to address further areas of emerging need in Pharma
R&D.
Microsaic Systems was established in 2001 by a team including
founders from Imperial College London, and was admitted to AIM in
2011 (ticker: MSYS).
www.microsaic.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRBCGDSXBGBGRL
(END) Dow Jones Newswires
April 07, 2017 02:00 ET (06:00 GMT)
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From Apr 2024 to May 2024
Microsaic Systems (LSE:MSYS)
Historical Stock Chart
From May 2023 to May 2024